| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/09/2005 | EP1504119A2 Method for ligating nucleic acids and molecular cloning |
| 02/09/2005 | EP1504117A2 Process for generating sequence-specific proteases by directed evolution and use thereof |
| 02/09/2005 | EP1504112A2 Development of a preventive vaccine for filovirus infection in primates |
| 02/09/2005 | EP1504111A2 Nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues, and methods of making same |
| 02/09/2005 | EP1504108A2 Viral vector |
| 02/09/2005 | EP1504107A1 Recombinant fowlpox virus |
| 02/09/2005 | EP1504106A2 Method of increasing plant organ and seed size in a plant |
| 02/09/2005 | EP1504105A1 Wound-inducible expression in plants |
| 02/09/2005 | EP1504104A1 Insect resistant plants and methods for making the same |
| 02/09/2005 | EP1504103A1 Promoters having a modified transcription efficiency and derived from methyltrophic yeast |
| 02/09/2005 | EP1504098A2 A method for in vitro molecular evolution of protein function |
| 02/09/2005 | EP1504097A2 Protein interaction system for multisubunit complexes |
| 02/09/2005 | EP1504096A2 Seed specific usp promoters for expressing genes in plants |
| 02/09/2005 | EP1504095A2 Site specific listeria integration vectors and methods for using the same |
| 02/09/2005 | EP1504093A2 Rna detection enzymes |
| 02/09/2005 | EP1504092A2 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination |
| 02/09/2005 | EP1504091A2 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants |
| 02/09/2005 | EP1504090A2 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors |
| 02/09/2005 | EP1504089A2 Allergen mutants |
| 02/09/2005 | EP1504088A2 Bacteriophages useful for therapy and prophylaxis of bacterial infections |
| 02/09/2005 | EP1504086A2 Control of es cell self renewal and lineage specification, and medium therefor |
| 02/09/2005 | EP1504085A1 Conductive microplate |
| 02/09/2005 | EP1504049A1 Monomers containing polyoxyalkylenes and polymer supports therefrom |
| 02/09/2005 | EP1504046A2 Tri-block polymers for nanosphere-based drug or gene delivery |
| 02/09/2005 | EP1504037A2 Ferritin fusion proteins for use in vaccines and other applications |
| 02/09/2005 | EP1504036A2 Toxin-related antibodies with antimicrobial and antiviral activity |
| 02/09/2005 | EP1504035A2 Antibodies specific for human cd22 and their therapeutic and diagnostic uses |
| 02/09/2005 | EP1504030A2 Constitutively translocating cell line |
| 02/09/2005 | EP1504029A2 Expression system for large functional proteins |
| 02/09/2005 | EP1504027A2 Adipocyte complement related protein zacrp8 |
| 02/09/2005 | EP1504017A2 Mutant chromophores/fluorophores and methods for making and using the same |
| 02/09/2005 | EP1504016A2 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
| 02/09/2005 | EP1503985A2 Polypeptides and biosynthetic pathways |
| 02/09/2005 | EP1503858A1 Substrate plate, method and apparatus for manufacturing such a substrate plate, and system for conducting bioassays comprising such a substrate plate |
| 02/09/2005 | EP1503801A2 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 02/09/2005 | EP1503793A2 Cancer vaccines and methods of using the same |
| 02/09/2005 | EP1503792A2 Attenuation of metapneumovirus |
| 02/09/2005 | EP1503788A2 Treatment of alpha-galactosidase a deficiency |
| 02/09/2005 | EP1503785A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 02/09/2005 | EP1503767A2 Compositions and methods for treatment of vitamin d deficiency |
| 02/09/2005 | EP1503758A1 Methods of modulating smooth muscle contractility |
| 02/09/2005 | EP1503745A2 15625 receptor, a novel g-protein coupled receptor |
| 02/09/2005 | EP1503627A2 High throughput screening assay for detecting a dna sequence |
| 02/09/2005 | EP1456223A4 Rapidly maturing fluorescent proteins and methods for using the same |
| 02/09/2005 | EP1399572A4 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants |
| 02/09/2005 | EP1373567A4 Detection of methylated cpg rich sequences diagnostic for malignant cells |
| 02/09/2005 | EP1343916A4 Nucleic acid amplification methods |
| 02/09/2005 | EP1339870B1 Methods for external controls for nucleic acid amplification |
| 02/09/2005 | EP1313885A4 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 02/09/2005 | EP1307591A4 Cation mediated triplex hybridization assay |
| 02/09/2005 | EP1261863B1 Method and apparatus for the location and concentration of polar analytes using an alternating electric field |
| 02/09/2005 | EP1255850A4 AMPLIFICATION OF $i(CYP24) AND USES THEREOF |
| 02/09/2005 | EP1242814B1 Flow cell for synthesis of arrays of dna probes and the like |
| 02/09/2005 | EP1228244A4 Methods and apparatuses for analyzing polynucleotide sequences |
| 02/09/2005 | EP1183516B1 Platform for chemical or biological analysis with microbalances, analysis device and method using same |
| 02/09/2005 | EP1082875A4 Improved brush block housing for propeller deicing system |
| 02/09/2005 | EP1056860B1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 02/09/2005 | EP1051427A4 Spoil protein and nucleic acid molecules and uses therefor |
| 02/09/2005 | EP1030923B1 Method for producing virus-like particles on the basis of polyoma viruses |
| 02/09/2005 | EP1017805B1 Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof |
| 02/09/2005 | EP1009805A4 TRANSGENIC PLANTS OF ALTERED MORPHOLOGY AND THE ISOLATED $i(ARABIDOPSIS THALIANA) ENDO-1,4-$g(b)-GLUCANASE GENE, PROMOTER AND PROTEIN |
| 02/09/2005 | EP0885238A4 Substituted nucleic acid mimics |
| 02/09/2005 | EP0828755A4 Method for molecular cloning and polynucleotide synthesis using vaccinia dna topoisomerase |
| 02/09/2005 | EP0700438B1 Opioid receptors: compositions and methods |
| 02/09/2005 | EP0383799B2 Adheson variants |
| 02/09/2005 | EP0365597B2 Improved processes for the treatment of vascular disease |
| 02/09/2005 | CN1578841A Annealing control primer and the use of the same annealing control primer |
| 02/09/2005 | CN1578840A Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
| 02/09/2005 | CN1578839A Modulating urea degradation in wine yeast |
| 02/09/2005 | CN1578838A Method and means for producing protein with prospective post-translation modification |
| 02/09/2005 | CN1578837A Regulated nucleic acid expression system |
| 02/09/2005 | CN1578836A Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 02/09/2005 | CN1578835A Aromatic methyltransferases and uses thereof |
| 02/09/2005 | CN1578834A Genes coding for metabolic pathway proteins |
| 02/09/2005 | CN1578832A Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants |
| 02/09/2005 | CN1578831A Fungal micro-organism having an increased ability to carry out biotechnological process(es) |
| 02/09/2005 | CN1578789A Hepatitis c virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
| 02/09/2005 | CN1578788A Pharmaceutical compositions, and a method of preparing and isolating said pharmaceutical compositions, and use of said pharmaceutical compositions for prophylactic treatment of lesions and carcinomas |
| 02/09/2005 | CN1578787A Vectors, constructs, and transgenic plants for hpv-11 and hpv-16 l1 capsid protein |
| 02/09/2005 | CN1578785A Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 02/09/2005 | CN1578678A Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/09/2005 | CN1576840A Methods for diagnosis and therapy of cancer and composition useful therein |
| 02/09/2005 | CN1576374A Production method and production apparatus of probe carrier |
| 02/09/2005 | CN1576370A Transgenic plant products comprising human granulocyte colony-stimulating factor and method for preparing the same |
| 02/09/2005 | CN1576369A Prawn leukasmus rhabdovirus dUTPase gene and coded polypeptide thereof |
| 02/09/2005 | CN1576368A Prawn leukasmus rhabdovirus VP26 gene correlated with infection and coded polypeptide thereof |
| 02/09/2005 | CN1576367A Prawn leukasmus rhabdovirus WP486 gene and coded polypeptide thereof |
| 02/09/2005 | CN1576366A A hematopoietic cell specific cell cycle control gene and its coded protein |
| 02/09/2005 | CN1576365A 葡萄糖脱氢酶 Glucose dehydrogenase |
| 02/09/2005 | CN1576364A Building identification and application for heterogenic interbone marrow filling stem cell transplantation chimeric model |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188528C Intercellular adhesion molecule-3 and its binding ligands |
| 02/09/2005 | CN1188525C Improved i (agrobacterium)-mediated transformation of plants |
| 02/09/2005 | CN1188524C Human SP-A1 expression in pichia pastoris |
| 02/09/2005 | CN1188523C Blue-green alga shuttle plasmid expression vector and method for expressing thymison alpha1 |
| 02/09/2005 | CN1188521C Coding of gene of protein with synthetic aurone activity |
| 02/09/2005 | CN1188520C Production of polyketies in plants |
| 02/09/2005 | CN1188519C Fusion proteins comprising HIV-1 Tat and /or Nef proteins |
| 02/09/2005 | CN1188516C Coded nucleotide sequence of recombinant nattokinase and process for producing the same nattokinase |
| 02/09/2005 | CN1188427C Recombinant chimeric peptide antigen for detecting HCMV antibody and production method thereof |